RCKT ROCKET PHARMACEUTICALS INC Other Situations 8-K Filing 2023 - Updates on Danon Disease Program Rocket Pharmaceuticals, Inc. provided updates on their Danon Disease Program, including alignment with the FDA on the design of a Phase 2 trial.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC